4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-097853
Chief Executive Officer sold 2,403 shares at $0.78 ($1,874)
From the SEC's structured data for this filing
Trades in this filing
Rawcliffe Adrian · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-01 | Sale : show line 1 in the form | −2,403 | $0.78 | $1,874 | 3,449 | D |
| Open-market sales · 2,403 sh · avg $0.78 · $1,874 | ||||||
Loading xslF345X05/tm2325388-1_4seq1.xml…